Abstract
Purpose To evaluate tear function test, corneal surface disorder in recently diagnosed hyperthyroid and hypothyroid patients and to compare results with healthy subjects.
Setting/Venue Mahatma Gandhi Medical College, Jaipur, Rajasthan, India
Methods Cross sectional analytical study. 30 recently diagnosed (within 3 months of diagnosis) patients of hyperthyroidism and hypothyroidism each and 30 healthy age matched controls were included. All patients and controls underwent assessment of proptosis, Palpebral fissure-height (PFH), tear function test (OSDI questionnaire, Schirmer’s test and Tear Break-up-time (TBUT) and Impression Cytology for ocular surface assessment. These parameters were compared between cases and controls. Standard statistical analysis was used.
Results Mean Proptosis and PFH showed no significant difference among groups (P value =0.071). Mean value of OSDI was 42.33+22.67, 41.15+16.03 and 29.33+6.84 in hyperthyroid, hypothyroid & Controls respectively, the difference being statistically significant (p=0.001).
Mean TBUT was 7.13+3.28 sec, 6.38+2.46 sec, and 11.15+2.39 sec in hyperthyroidism, hypothyroidism and controls respectively (p=0.001). Mean value of Schirmer tear test was 12.93+5.81mm, 13.30+4.44mm, and 17.55+7.35mm in hyperthyroidism, Hypothyroidism and controls respectively (p=0.001). 80% of patients in hyperthyroidism group had grade 2-3 squamous metaplasia as compared to 70% in hypothyroidism patients and 24.4% in controls, signifying ocular surface damage (p<0.05).
Conclusions Mean PFH and proptosis did not differ between three groups. However, increased OSDI score, decreased Schirmer’s test value, decreased TBUT and grade 2-3 squamous metaplasia in patients of thyroid dysfunction suggests presence of dry eyes. Despite no clinically visible signs of thyroid ophthalmopathy, there is ocular surface damage right from the early stages of thyroid dysfunction. This is attributable to evaporative mechanism as well as ocular surface inflammation and hyperosmolarity of tear film.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
None
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional Ethics committee, Mahatma Ganghi Medical College, Jaipur
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflict of Interest None
Data Availability
All the data mentioned in the manuscript is available in the manuscript attached.